DB
ADPT icon

Dmitry Balyasny’s Adaptive Biotechnologies ADPT Stock Holding History

Dmitry Balyasny’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-426,462
Closed -$6.93M – 2820
2025
Q4 		$6.93M Buy
+426,462
New +$6.96M 0.01% 1219
2025
Q1 		– Sell
-53,170
Closed -$319K – 2736
2024
Q4 		$319K Buy
+53,170
New +$293K ﹤0.01% 2362
2024
Q3 		– Sell
-29,227
Closed -$106K – 2690
2024
Q2 		$106K Buy
29,227
+9,341
+47% +$29.6K ﹤0.01% 2399
2024
Q1 		$63.8K Buy
+19,886
New +$76.9K ﹤0.01% 2515
2022
Q3 		– Sell
-618,658
Closed -$5M – 2810
2022
Q2 		$5M Buy
+618,658
New +$5.44M 0.02% 934
2022
Q1 		– Sell
-76,324
Closed -$2.14M – 2431
2021
Q4 		$2.14M Sell
76,324
-61,932
-45% -$1.9M 0.01% 1181
2021
Q3 		$4.7M Buy
138,256
+99,222
+254% +$3.59M 0.02% 843
2021
Q2 		$1.59M Buy
+39,034
New +$1.52M 0.01% 1088
2021
Q1 		– Sell
-50,521
Closed -$2.99M – 1710
2020
Q4 		$2.99M Sell
50,521
-132,113
-72% -$6.81M 0.02% 783
2020
Q3 		$8.88M Buy
182,634
+161,731
+774% +$6.8M 0.07% 421
2020
Q2 		$1.01M Buy
+20,903
New +$762K 0.01% 830
2020
Q1 		– Sell
-424,087
Closed -$12.7M – 1116
2019
Q4 		$12.7M Buy
+424,087
New +$12.2M 0.08% 360

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dmitry Balyasny's ADPT Position: Q1 2026 in Review

Dmitry Balyasny sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 426,462 shares — an estimated $6.93M sold.

Dmitry Balyasny first reported a position in ADPT in Q4 2019 and held it in 12 quarters. The position peaked at $12.7M in Q4 2019. 297 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Dmitry Balyasny reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 426,462 Adaptive Biotechnologies shares in Q1 2026, an estimated $6.93M.
  • Dmitry Balyasny first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 12 quarters.
  • Dmitry Balyasny's Adaptive Biotechnologies position peaked at $12.7M in Q4 2019.
  • 297 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.